1. Home
  2. ESLT vs RPRX Comparison

ESLT vs RPRX Comparison

Compare ESLT & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESLT
  • RPRX
  • Stock Information
  • Founded
  • ESLT 1966
  • RPRX 1996
  • Country
  • ESLT Israel
  • RPRX United States
  • Employees
  • ESLT N/A
  • RPRX N/A
  • Industry
  • ESLT Military/Government/Technical
  • RPRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ESLT Industrials
  • RPRX Health Care
  • Exchange
  • ESLT Nasdaq
  • RPRX Nasdaq
  • Market Cap
  • ESLT 13.8B
  • RPRX 14.4B
  • IPO Year
  • ESLT 1996
  • RPRX 2020
  • Fundamental
  • Price
  • ESLT $357.03
  • RPRX $33.01
  • Analyst Decision
  • ESLT
  • RPRX Strong Buy
  • Analyst Count
  • ESLT 0
  • RPRX 5
  • Target Price
  • ESLT N/A
  • RPRX $41.60
  • AVG Volume (30 Days)
  • ESLT 44.2K
  • RPRX 4.9M
  • Earning Date
  • ESLT 03-18-2025
  • RPRX 02-11-2025
  • Dividend Yield
  • ESLT 0.54%
  • RPRX 2.67%
  • EPS Growth
  • ESLT N/A
  • RPRX N/A
  • EPS
  • ESLT 5.85
  • RPRX 1.91
  • Revenue
  • ESLT $6,523,449,000.00
  • RPRX $2,263,576,000.00
  • Revenue This Year
  • ESLT $14.58
  • RPRX $31.61
  • Revenue Next Year
  • ESLT $11.57
  • RPRX $5.51
  • P/E Ratio
  • ESLT $61.08
  • RPRX $17.27
  • Revenue Growth
  • ESLT 11.41
  • RPRX N/A
  • 52 Week Low
  • ESLT $175.30
  • RPRX $24.05
  • 52 Week High
  • ESLT $359.08
  • RPRX $34.20
  • Technical
  • Relative Strength Index (RSI)
  • ESLT 85.81
  • RPRX 57.23
  • Support Level
  • ESLT $294.99
  • RPRX $33.06
  • Resistance Level
  • ESLT $359.08
  • RPRX $34.10
  • Average True Range (ATR)
  • ESLT 6.22
  • RPRX 0.73
  • MACD
  • ESLT 5.43
  • RPRX -0.17
  • Stochastic Oscillator
  • ESLT 96.80
  • RPRX 45.91

About ESLT Elbit Systems Ltd.

Elbit Systems Ltd is a technology company involved in producing a portfolio of systems and products for aircraft, land, and naval applications. The company's products are used for defense, homeland security, and commercial flight capabilities. Its systems and solutions may be installed on new platforms, or it may perform a comprehensive modernization program to transform a platform. Elbit Systems gives instructions to its customers on the proper maintenance of its products and will provide support team specialists when the customer cannot fix a problem. The company markets its systems and products as a prime contractor or as a subcontractor to government, defense, and homeland security contractors world wide.

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Share on Social Networks: